Opiant Pharmaceuticals to Report Fourth Quarter 2021 Financial Results and Host Conference Call and Webcast on March 15, 2022

Rhea-AI Summary

Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) will report its fourth quarter 2021 financial results and pipeline updates on March 15, 2022, after market close. The management team will host a conference call at 4:30 p.m. ET that same day, which can be accessed via phone or live webcast. Opiant is known for developing NARCAN® Nasal Spray and is focused on creating new medications for addiction and overdose treatment.

Positive

• Opiant is developing a strong portfolio of medicines for addiction and overdose.
• The upcoming conference call may provide insights into financial performance and pipeline advancements.

Negative

• None.

SANTA MONICA, Calif., March 07, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report fourth quarter 2021 financial results and pipeline updates on Tuesday, March 15, 2022, after U.S. financial markets close.

The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Tuesday, March 15, 2022. To access the call, please dial 1-877-407-0792 in the U.S., or 1-201-689-8263, outside the U.S. and provide the conference ID number: 13726931. To access the live webcast, please visit https://themediaframe.com/mediaframe/webcast.html?webcastid=FPHqejQp. Following the live webcast, an archived version of the call will be available on the website.

Tuesday March 15 @ 4:30 pm ET
Domestic:	1-877-407-0792
International:	1-201-689-8263
Conference ID:	13726931
Webcast:	https://themediaframe.com/mediaframe/webcast.html?webcastid=FPHqejQp

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com and follow Opiant on Twitter (@Opiant_Pharma).

For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com

FAQ

When will Opiant Pharmaceuticals report its fourth quarter 2021 financial results?

Opiant Pharmaceuticals will report its fourth quarter 2021 financial results on March 15, 2022.

What time is the Opiant Pharmaceuticals conference call scheduled for?

The Opiant Pharmaceuticals conference call is scheduled for 4:30 p.m. ET on March 15, 2022.

How can I access the Opiant Pharmaceuticals conference call?

You can access the Opiant Pharmaceuticals conference call by dialing 1-877-407-0792 in the U.S. or 1-201-689-8263 internationally.

Is there a webcast available for the Opiant Pharmaceuticals call?

Yes, the conference call will also be available via a live webcast on Opiant's website.